Prosecution Insights
Last updated: April 19, 2026

Milstein Zhang & Wu LLC

24 pending office actions • 14 clients

Portfolio Summary

24
Total Pending OAs
8
Final Rejections
16
Non-Final OAs

Client Portfolio (14 clients)

Client (Assignee)Pending OAs
UNIVERSITY OF MASSACHUSETTS 5
Shenzhen Hightide Biopharmaceutical, Ltd. 3
Microvascular Therapeutics, LLC 3
NuvOx Pharma LLC 2
Shenzhen Hightide Biopharmaceutical Ltd. 2
Crimson Biopharm Inc. 1
Alfred E. Tiefenbacher GmbH & Co. KG 1
Canwell Biotech Limited 1
1Globe Health Institute LLC 1
Xtalpi, Inc. 1
Yanping Kong 1
BIOVENTURES, LLC 1
1Globe Health Institute, Nanjing 1
University of Rhode Island Board of Trustees 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18648420 ISO-OSMOTIC AND NEAR ISO-OSMOTIC OXYGEN THERAPEUTIC FORMULATIONS AND METHODS THEREOF NuvOx Pharma LLC BAEK, BONG-SOOK 1611 Non-Final OA Apr 28, 2024
18630270 BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF Shenzhen Hightide Biopharmaceutical, Ltd. WILLIS, DOUGLAS M 1624 Non-Final OA Apr 09, 2024
18574248 CRYSTALLINE POLYMORPHS OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR, AND COMPOSITIONS AND METHODS THEREOF Crimson Biopharm Inc. COLEMAN, BRENDA LIBBY 1624 Non-Final OA Dec 26, 2023
18519269 Pharmaceutical Mixture Comprising Amorphous Pitolisant Alfred E. Tiefenbacher GmbH & Co. KG KIM, SEONG JONG 1621 Non-Final OA Nov 27, 2023
18387769 METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE Shenzhen Hightide Biopharmaceutical, Ltd. BOECKELMAN, JACOB A 1655 Non-Final OA Nov 07, 2023
18287301 FLUOROCARBON COMPOSITIONS AND METHODS FOR ENHANCING IMMUNOTHERAPY NuvOx Pharma LLC SAEED, KAMAL A 1626 Non-Final OA Oct 18, 2023
18280548 METAP-2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS THEREOF Canwell Biotech Limited COPPINS, JANET L 1628 Non-Final OA Sep 06, 2023
18277846 Novel Compositions for Conjugating Oligonucleotides and Carbohydrates 1Globe Health Institute LLC RYAN, DOUGLAS CHARLES 1635 Non-Final OA Aug 18, 2023
18233077 PROTEIN-POLYMER NANOASSEMBLIES AND INTRACELLULAR PROTEIN DELIVERY UNIVERSITY OF MASSACHUSETTS YOON, TAE H 1762 Non-Final OA Aug 11, 2023
18273634 PHOSPHOINOSITIDE 3 KINASE BETA INHIBITORS AND COMPOSITIONS AND METHODS THEREOF Xtalpi, Inc. ROMERO, KRISTEN WANG 1624 Non-Final OA Jul 21, 2023
18272939 COMPOSITIONS AND METHODS FOR TREATING CANCER Yanping Kong GAUGER, PAUL RANDALL 1629 Non-Final OA Jul 18, 2023
18219656 COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES Microvascular Therapeutics, LLC VU, JAKE MINH 1618 Non-Final OA Jul 08, 2023
18208672 PROTEIN-TEMPLATED SELF-ASSEMBLY OF A COVALENT POLYMER NETWORK FOR INTRACELLULAR TRAFFICKING AND TRACELESS RELEASE UNIVERSITY OF MASSACHUSETTS ROGERS, JAMES WILLIAM 1618 Non-Final OA Jun 12, 2023
18202033 COMPOSITIONS OF BERBERINE URSODEOXYCHOLATE AND METHODS THEREOF FOR TREATING PRIMARY SCLEROSING CHOLANGITIS Shenzhen Hightide Biopharmaceutical Ltd. BARSKY, JARED 1628 Final Rejection May 25, 2023
18134495 BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF Shenzhen Hightide Biopharmaceutical, Ltd. WILLIS, DOUGLAS M 1624 Final Rejection Apr 13, 2023
18088544 POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY UNIVERSITY OF MASSACHUSETTS POPA, ILEANA 1633 Final Rejection Dec 24, 2022
18081604 NANODEVICES AND METHODS FOR MEASURING BIOFLUIDIC FLOW USING A GRAPHENE-BASED MICROELECTRODE UNIVERSITY OF MASSACHUSETTS MONTGOMERY, MELISSA JO 3791 Final Rejection Dec 14, 2022
18078924 DODECAFLUOROPENTANE EMULSION AS A STROKE AND ISCHEMIA THERAPY BIOVENTURES, LLC SCHUBERG, LAURA J 1631 Non-Final OA Dec 10, 2022
17910779 CROSS-LINKED MEDICATION FOR TREATMENT OF CORONAVIRAL INFECTION AND METHOD OF TREATMENT 1Globe Health Institute, Nanjing SCHACHERMEYER, SAMANTHA LYNN 1693 Final Rejection Nov 09, 2022
17966782 COMPOSITIONS OF BERBERINE URSODEOXYCHOLATE AND METHODS THEREOF FOR TREATING FATTY LIVER DISEASE, DIABETES AND HYPERLIPIDEMIA Shenzhen Hightide Biopharmaceutical Ltd. WARD, PAUL V 1622 Non-Final OA Oct 15, 2022
17790697 ALKYLATED NUCLEOSIDES, AND COMPOSITIONS AND METHODS THEREOF FOR NUCLEIC ACID DELIVERY Microvascular Therapeutics, LLC CHO, DAVID H 1693 Final Rejection Jul 01, 2022
17777363 COMPOSITIONS AND METHODS FOR OPTOGENETIC IMMUNOTHERAPY UNIVERSITY OF MASSACHUSETTS SUNSHINE, HANNAH LOUISE 1647 Final Rejection May 17, 2022
17719015 High-Density Flagellin-Displaying Virus-Like Particle As Vaccine Carrier University of Rhode Island Board of Trustees LOUNTOS, GEORGE THEMISTOCLIS 1652 Non-Final OA Apr 12, 2022
17616166 COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES Microvascular Therapeutics, LLC VU, JAKE MINH 1618 Final Rejection Dec 02, 2021

Managing Milstein Zhang & Wu LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month